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TISSUE RESIDENT LYMPHOCYTES IN HUMAN SPINAL ENTHESES 
MICAH LEFTON 
ABSTRACT 
Objective: Ankylosing spondylitis (AS) is an inflammatory disorder within the 
spondyloarthritis family of rheumatic diseases. AS is characterized by chronic 
inflammation at entheses, the attachment sites of ligaments or tendons to bone, most 
prominently in the spine. Chronic enthesitis leads to pathological new bone formation, 
fusion of vertebral bodies and loss of spinal mobility. Studies in mice identified discrete 
subsets of enthesis-resident lymphocytes that function within the IL-23/IL-17A signaling 
pathway and are thought to play a critical role in mediating inflammation and new bone 
formation. Little is known about such enthesis-resident lymphocytes in humans. The goal 
of this project was therefore to develop methods to isolate lymphocytes from spinal 
entheses and analyze them in vitro. 
Methods: Cell preparation and staining conditions were optimized using 
peripheral blood mononuclear cells (PBMCs). We compared surface marker staining of 
PBMCs exposed to collagenase D, Liberase TL, and dispase II. In addition, we compared 
the staining of multiple antibody clones specific for CD56 and CD4. 
To measure cytokine expression, cells were stimulated with PMA/ionomycin for 
4 hours in the presence of monensin and brefeldin A. Following stimulation, the cells 
were stained with a 17-color staining panel enabling the identification of 8 lymphocyte 
subsets, 3 killer immunoglobin-like receptors (KIRs), and 4 cytokines implicated in AS 
pathology. Cell were analyzed on a 5 laser LSRFortessa flow cytometer. 
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Spine tissue was obtained from laminectomy surgeries performed on patients with 
degenerative disease of the spine. Interspinous ligament and spinous process bone were 
cut into 5 mm pieces and cryopreserved in CryoStor CS10, a serum free cryopreservation 
medium. Samples were stored at -80° C until analysis. After thawing, samples were 
digested with collagenase D to generate single cell suspensions for analysis by flow 
cytometry. 
Results: Incubation of lymphocytes with collagenases resulted in variable signal 
attenuation for CD56, CD4, and KIR3DL2. Loss of signal for CD56 occurred with all 
enzymes and anti-CD56 clones tested but correlated with duration of enzyme exposure. 
For the anti-CD4 clone OKT4, fluorescence remained stable after digestion. KIR3DL2 
signal was lost after incubation with Liberase TL but was not affected by collagenase D. 
Spine tissue samples contained the same lymphocyte subsets present in peripheral 
blood: natural killer (NK) cells, CD4+ T cells, CD8+ T cells, double negative αβ T cells, 
mucosal-associated invariant T (MAIT) cells, and γδ T cells including vδ1 and vδ2 cells. 
PMA/ionomycin-stimulated CD4+ T cells from a spine tissue donor had higher fractions 
of IL-17A and IL-22 positive cells compared to PBMCs from unmatched donors. 
Granulocyte-macrophage colony-stimulating factor (GM-CSF) production was also 
increased in spine tissue compared to unmatched PBMCs. 
Conclusion: Here we describe an optimized method for releasing lymphocytes 
from cryopreserved spine tissue specimens with minimal impact on surface marker 
detection. Similar populations of lymphocytes could be detected in spine tissue and 
peripheral blood. Stimulation of tissue-resident lymphocytes induced them to produce 
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inflammatory cytokines. The methods described will be useful to analyze a larger sample 
size and further characterize the lymphocytes resident to spinal entheses. 
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INTRODUCTION 
Spondyloarthritis (SpA) is a group of inflammatory rheumatic diseases with 
overlapping clinical features and shared pathophysiology. SpA can be broadly classified 
as either axial or peripheral SpA, depending on whether the disease predominantly affects 
the spine or peripheral joints. The prototypical axial SpA is ankylosing spondylitis 
(AS).18 AS starts before age 45, with 80% of patients experiencing symptoms prior to the 
age of 30.4 The typical AS patient complains about back pain that started insidiously, 
worsens with rest or during sleep and improves with activity.19 Chronic inflammation is 
the likely cause of back pain in AS patients.19 Some of the earliest detectable 
inflammation can be seen with magnetic resonance imaging (MRI) of the sacroiliac 
joints.19 Radiographic changes such as syndesmophytes, can be seen in the spine as the 
disease progresses.19 At late stages, patients experience a permanent loss of spinal 
mobility as vertebral bodies fuse secondary to formation of bridging syndesmophytes.19 
 
Epidemiology 
The prevalence of axial SpA in the United States is 0.9-1.4%.13 Global prevalence 
varies. The variability of AS prevalence across regions can be largely attributed to 
genetic factors, particularly a strong association with the gene for Human Leukocyte 
Antigen B27 (HLA-B27).15 Different populations around the world have varying 
frequencies of HLA-B27.15 In addition, males and females have a different prevalence of 
AS. While males have historically been diagnosed at higher rates than females, the 
difference in incidence between males and females has been shrinking in recent years.5 
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This trend is likely the result of new classification criteria and increased use of MRI in 
diagnosis.5 
 
Pathophysiology 
IL-23/IL-17A Axis. Immune responses can be globally classified into three major 
types based on the cytokines involved.12 One proposed mechanism for the development 
of AS is activation of a type 3 immune response.12 It is thought that various forms of 
stress, such as mechanical, microbial, or cellular, can lead to production of the 
proinflammatory cytokines IL-1β and IL-23 by stromal and myeloid cells.9 IL-23 in turn 
activates lymphocytes expressing retinoic acid receptor-related orphan receptor-γt, a 
transcription factor that controls the expression of IL-17A.6,12 These cells include CD4+ T 
helper 17 (Th17) cells, CD8+ T cytotoxic 17 (Tc17) cells, mucosal-associated invariant T 
(MAIT) cells, group 3 innate lymphoid cells (ILC3), and some γδ T cells.12,18 IL-17A 
promotes inflammation by activating IL-17 receptor-expressing stromal cells. One way 
IL-17A contributes to AS pathogenesis is by altering the activity of osteoclasts and 
osteoblasts consequently leading to abnormal bone formation.9,12 
Other cytokines have also been shown to play a role in AS. IL-22 works with 
IL-17A to support osteoclastogenesis and is produced by many of the same lymphocytes 
that make IL-17A.9,12 GM-CSF is produced by numerous populations of activated 
lymphocytes.17 It stimulates progenitors of macrophages and granulocytes to proliferate 
and its overexpression can lead to severe inflammation.17 Another important cytokine is 
interferon γ (IFNγ). IFNγ is primarily released by natural killer (NK) cells, CD8+ T cells, 
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and Th1 cells in response to intracellular pathogens.8,9 IFNγ promotes macrophage 
activity to assist in clearing infected cells.9 
HLA-B27. The HLA-B27 gene confers the greatest genetic risk for developing 
AS.12,15,18 There are multiple hypotheses for how HLA-B27 may contribute to disease. 
The first concerns the presentation of an arthritogenic peptide.18 HLA-B27 belongs to the 
major histocompatibility (MHC) class I family of surface proteins.12,18 MHC class I 
proteins are expressed on all cells except red blood cells. They function by binding 
intracellular peptides and presenting them on the cell surface for recognition by CD8+ T 
cells.18 It has been hypothesized that HLA-B27 presents certain arthritogenic peptides 
thereby driving a CD8+ T cell-mediated immune response.18 Antigen-experienced 
cytotoxic T cells are thought to be reactivated in the spine and joints leading to tissue 
inflammation and disease. Another hypothesis on the relationship of HLA-B27 and AS 
relates to the intrinsic instability of HLA-B27.18 Improperly folded HLA-B27 induces an 
unfolded protein response in the cell causing it to produce proinflammatory cytokines, 
such as IL-1β and IL-23 in myeloid cells.12,18 A third hypothesis involves the interaction 
of HLA-B27 with the receptor KIR3DL2 and other killer-immunoglobulin-like receptor 
(KIRs). HLA-B27 can abnormally arrange as a heavy chain homodimer lacking β2-
microglobulin.18 HLA-B27 homodimers have been shown to bind KIR3DL2.12,18  
Killer Immunoglobulin-Like Receptors. KIR3DL2 belongs to the KIR family of 
receptor types which recognize MHC class I proteins. KIRs are expressed in NK cells, 
antigen-experienced CD4+ and CD8+ T cells, as well as γδ T cells.1,8 A KIR is comprised 
of either two or three extracellular immunoglobin-like domains and a variable length 
 4 
cytoplasmic domain.8 Long cytoplasmic domains contain an inhibitory motif whereas 
short cytoplasmic domains facilitate the interaction with adaptor proteins containing 
activation motifs.8 KIR3DL2 is an inhibitory KIR that can bind to HLA-B27 
homodimers.1,8 Expression of KIR3DL2 is significantly increased on NK and Th17 cells 
in patients with SpA.1 It has been hypothesized that KIR3DL2 protects NK and Th17 
cells from activated-induced apoptosis.1 In addition, KIR3DL2 expressing NK cells have 
greater cytotoxic activity and Th17 cells release more IL-17A.1,14 Th17 cells have also 
been shown to upregulate expression of KIR3DL2 upon activation.1,14 This evidence 
supports a role for the interaction of KIR3DL2 expressing lymphocytes and HLA-B27 
homodimers in AS pathogenesis. Another inhibitory KIR, KIR3DL1 binds to properly 
assembled MHC class I complexes of HLA-B27 heavy chain, peptide and β2 
microglobulin.1,8 However the role of KIR3DL1 involvement in AS is less clear. One 
study showed no difference in KIR3DL1 expression in healthy patients compared to 
patients with either SpA or rheumatoid arthritis.1 A different study hypothesized that NK 
cells with KIR3DL1 may have reduced cytotoxic capability.7 
Enthesitis. Inflammation at entheses, the attachment sites of tendons and 
ligaments to bone, features prominently in SpA pathogenesis and is hypothesized to be 
the key process driving inflammation in AS.11 In contrast, synovitis, the primary disease 
process in rheumatoid arthritis, is thought to be a secondary event in SpA occurring as the 
result of local cytokine release at inflamed entheses.11 Mechanical loading of entheses 
has been shown to activate inflammation and new bone formation.12,18 Another 
mechanism of enthesitis involves the IL-23/IL-17A pathway. Overexpression of IL-23 in 
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a mouse model induced enthesitis at the Achilles tendon insertion.16 IL-23 responsive 
cells have recently been found in the enthesis of human spine tissue and have been 
proposed to play a role in SpA pathogenesis.2 In vitro stimulation of entheseal spine 
tissue with IL-1β and IL-23 increased the expression of IL-17A.2 However, the 
phenotype of the cells producing IL-17A and other pro-inflammatory cytokines in human 
entheses has not been fully elucidated. 
 
Objective 
The goal of this project was to optimize methods for the isolation of lymphocytes 
from human spinal entheses and to compare single cell suspensions prepared from spine 
tissue with peripheral blood lymphocytes using multi-color flow cytometry. 
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METHODS 
Peripheral Blood Mononuclear Cells (PBMC) 
Collection. Apharesis leukoreduction collars were obtained from the Brigham and 
Women’s Hospital blood bank and diluted 1:1 in Hanks’ Balanced Salt Solution (HBSS) 
(Corning). Specimens were layered on top of Ficoll-Paque PLUS (GE Healthcare) and 
centrifuged at 500 g, 20° C, for 30 minutes. The mononuclear cell layer was collected and 
resuspended in HBSS. 
Cryopreservation. PBMCs were centrifuged at 300 g, 4° C, for 10 minutes. Cells 
were resuspended in fetal bovine serum (FBS) (Gemini) containing 10% dimethyl 
sulfoxide (Sigma Aldrich) at a density of 10-15 million cells/mL. 1 mL of suspension 
was transferred to a 1.8 mL cryovial (Thermo Fisher Scientific) and placed in a Mr. 
Frosty (Thermo Fisher Scientific), an insulated plastic box containing a layer of 
isopropanol for a controlled rate of cooling (-1° C per minute) in a -80° C freezer. 
Cryovials were stored at -80° C until use. 
 
In Vitro Stimulation 
Cells were resuspended in IMDM-C (Iscove's Modified Dulbecco's Medium 
(Gibco) supplemented with 10% FBS, 10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) (Cellgro), 1 mM sodium pyruvate (Cellgro), 2 
mM L-glutamine (Gibco), 1 U/mL penicillin (Sigma Aldrich), 1 μg/mL streptomycin 
(Sigma Aldrich), nonessential amino acids (Cellgro), and 50 μM 2-mercaptoethanol 
(Gibco)) and stimulated in a 96-well round-bottom plate with 81 nM phorbol 12-
 7 
myristate 13-acetate (PMA) and 134 nM ionomycin (Thermo Fisher Scientific) in the 
presence of monensin (GolgiStop, BD Bioscience) and brefeldin A (GolgiPlug, BD 
Bioscience) for 4 hours at 37° C in 5% CO2. 
 
Flow Cytometry 
Staining was performed in 96-well round-bottom plates. Cells were first washed 
with HBSS and incubated in HBSS containing the Fixable Viability Dye (FVD) eFluor 
455UV (Thermo Fisher Scientific) for 15 minutes at 4° C. The Fc receptor was blocked 
by incubating in Human TrueStain FCX (BioLegend) for 20 minutes at room 
temperature. For staining of cell surface markers, cells were incubated in staining buffer 
(HBSS supplemented with 2 μM ethylenediaminetetraacetic acid (EDTA) (Boston 
BioProducts) and 0.5% bovine serum albumin (BSA) (Sigma Aldrich)) containing 
antibodies for extracellular proteins as listed in Table 1. Incubation was carried out for 30 
minutes at 4° C in the dark. After washes with staining buffer, cells were fixed by 
incubating in IC Fixation Buffer (Thermo Fisher Scientific) for 15 minutes at room 
temperature and washed 3 times in Permeabilization Buffer (Thermo Fisher Scientific). 
Cells were then incubated in Permeabilization Buffer containing antibodies for 
intracellular targets, as listed in Table 1, for 30 minutes at room temperature in the dark. 
After intracellular staining, cells were washed 3 times with Permeabilization 
Buffer, resuspended in staining buffer, and analyzed on a LSRFortessa (BD Bioscience). 
The flow cytometer’s photomultiplier tubes (PMT) settings were optimized for use with 
the staining panel, see appendix below. 
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Color Marker Clone Dilution Company 
BUV395 FVD  1:500 Thermo Fisher 
BUV496 CD8 RPA-T8 1:200 BD Bioscience 
BV421 MR-1 tetramer 5-OP-RU 1:500 NIH 
BV510 αβ TCR IP26 1:200 BioLegend 
BV605 CD4 OKT4 1:200 BioLegend 
BV650 IFNγ 4S.B3 1:100 BioLegend 
BV711 vδ2 TCR B6 1:200 BioLegend 
BV786 CD56 5.1H11 1:200 BioLegend 
FITC vδ1 TCR REA173 1:200 BioLegend 
PerCP-Cy5.5 KIR3DL1 DX9 1:400 BioLegend 
PE KIR3DL2 DX31 1:500 UCSF 
PE-Dazzle GM-CSF BVD2-21C11 1:100 BioLegend 
PE-Cy5 
CD14 61D3 1:500 eBioscience 
CD19 HIB19 1:500 BioLegend 
PE-Cy7 IL-22 2G12A41 1:100 BioLegend 
APC KIR3DL1/DS1 Z27 1:100 
Beckman 
Coulter 
AF 700 CD3 UCHT1 1:200 BioLegend 
APC-Cy7 IL-17A BL168 1:100 BioLegend 
Table 1. Finalized staining panel used for flow cytometry analysis. This panel was modified from 
one previously used in the lab. IL-22 was added as a parameter, and the clones for CD4 and 
KIR3DL1/DS1 were exchanged. Antibody dilutions were empirically determined, see appendix 
below. 
 
Digestive Enzyme and Antibody Clone Selection 
We suspended 1.5 x 106 PBMCs in 1 mL of Dulbecco’s Modified Eagle’s 
Medium (DMEM) (Gibco) supplemented with 0.5% BSA and either 1 mg/mL 
collagenase D (Roche), 1 mg/mL dispase II (Roche), 0.1 mg/mL Liberase TL (Roche), or 
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0.5 mg/mL hyaluronidase (Sigma Aldrich). Cells were incubated at 37° C on a shaking 
table for either 0, 20, 40, or 60 minutes. The cells were then stained for extracellular 
markers, method described above, and analyzed on a LSRFortessa. 
In addition to testing multiple digestive enzymes, we also compared multiple 
antibody clones for CD4 and CD56 and compared the median fluorescent intensity (MFI) 
to PBMCs that were incubated without addition of enzymes. 1.5 x 106 PBMCs were 
suspended in 1 mL of DMEM supplemented with 0.5% BSA and either 1 mg/mL 
collagenase D, 1 mg/mL dispase II, or 0.1 mg/mL Liberase TL. Cells were incubated at 
37° C on a shaking table for 60 minutes. The cells were then stained for extracellular 
markers. For CD56, the clone used was either 5.1H11, HCD56, MEM188, or QA17A16. 
For CD4, the clone was either RPAT4, SK3, or OKT4. 
Lastly, as no alternative antibody clones were available for KIR3DL2, we 
examined if KIR3DL2 fluorescence would recover by allowing cells to rest after 
digestion. 1.5 x 106 PBMCs were incubated in DMEM, 0.5% BSA with either 1 mg/mL 
collagenase D or 0.1 mg/mL Liberase TL at 37° C for 40 minutes. Cells were washed and 
analyzed either immediately or after resting in RPMI-C (Roswell Park Memorial Institute 
medium (Gibco) supplemented as described for IMDM-C) at 37° C for 4 or 12 hours. 
 
Spine Tissue 
Collection. Discarded lumbar spinous process bone and interspinous ligament 
specimens were obtained from non-AS patients undergoing surgical laminectomy for 
spinal decompression (Figure 1). Specimens were obtained from the Department of 
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Orthopedic Surgery at Brigham and Women’s Hospital and Brigham and Women’s 
Faulkner Hospital. Following surgery, tissue was transported in sterile normal saline and 
immediately processed. Tissue was rinsed in HBSS and remained submerged in HBSS 
throughout processing. Using scissors, soft tissue was cut away from the spinous process. 
The bone was cut transversely with shears and cut again along its sagittal plane (Figure 
1). Most of the marrow and trabecular bone was cleared away. Bone was then cut into 5 
mm diameter pieces for analysis. Interspinous ligament adjacent to bone was cut into less 
than 5 mm pieces using scissors (Figure 1). 
 
Figure 1. Left: Spinous process L2 through L5 from a laminectomy surgery. The interspinous 
ligament in the outlined selection was dissected for analysis. Right: Spinous process after 
removal of the surrounding soft tissue. The bone was first transversely cut in half and then 
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dissected along the sagittal plane to approximate mid-point. The circled section was removed for 
analysis. 
 
Cryopreservation. Ligament or bone tissue pieces were added to 1 mL of 
CryoStor CS10 (BioLife Solutions) in a cryovial until the final volume reached 1.5 mL. 
Cryovials were frozen as described above and stored at -80° C. 
Enzymatic Digestion. Frozen tissue samples were thawed by manually stirring the 
cryovial in a 37° C water bath. After thawing, the tissues pieces were removed from the 
cryovial, rinsed with DMEM supplemented with 0.5% BSA and then placed in 2.5 mL of 
DMEM with 0.5% BSA, 1 mg/mL collagenase D (Sigma Aldrich), and 100 μg/mL 
DNase I (Sigma Aldrich). Interspinous ligament specimens were further minced with 
scissors. Samples were incubated for 40 minutes at 37° C on a shaking table. Following 
digestion, the tissue was ground through a 70 μm cell strainer and washed with RPMI-C. 
 
Flow cytometry and Statistical Analysis 
Analysis of flow cytometry data was done using FlowJo V10.5.3. Statistical 
analysis and graphing were performed using GraphPad Prism 7. P values were calculated 
using the paired or unpaired Student’s t test. P values less than 0.05 were considered 
significant. 
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RESULTS 
Flow Cytometry Gating Strategy 
The flow cytometry staining panel (Table 1), modified from a staining panel 
previously developed in the lab, can identify 8 lymphocyte populations, explained below, 
as well as the receptors KIR3DL2, KIR3DL1, KIR3DS1, and the cytokines IL-17A, 
IL-22, GM-CSF, and IFNγ. Figure 2 shows the gating strategy on a representative 
example of PBMCs from a healthy individual. Lymphocytes are gated based on forward 
scatter (FSC) and side scatter (SSC), and doublets are excluded. FVD+ non-viable cells, 
CD14+ monocytes and CD19+ B cells are excluded. Next, NK cells are identified as CD3-
CD56+ cells. CD3+ T cells are then separated into αβ T cell receptor positive and negative 
fractions. CD3+αβTCR- cells represent γδ T cells and can be distinguished further as vδ1 
cells, vδ2 cells, or other γδ T cells. MAIT cells are identified as CD3+αβTCR+MR1+. 
CD3+αβTCR+MR1- cells are separated based on expression of CD4 and CD8 into CD4+ 
T cells, CD8+ T cells and CD4-CD8- DN αβ T cells. These lymphocyte subsets can then 
be analyzed for expression of KIRs or induction of cytokines upon stimulation with 
PMA/ionomycin. 
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Figure 2. Flow cytometry gating strategy on a sample of PBMCs from a healthy donor to identify 
8 lymphocytes populations: NK Cells (middle right), MAIT cells (middle left), CD4+ T cells 
(bottom left), CD8+ T cells (bottom left), DN αβ T cells (bottom left), vδ1 T cells (bottom 
middle), vδ2 T cells (bottom middle), and other γδ T cells (bottom middle). 
 
Digestive Enzymes and Antibody Clones 
To test the conditions for lymphocyte isolation from spine tissue, we incubated 
PBMCs with digestive enzymes followed by flow cytometric analysis for cells surface 
markers using the panel described above. While most markers were unaffected by 
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enzymatic digestions, we observed significant effects on CD56, CD4, and KIR3DL2 
signals. The CD56 MFI gradually decreased over time in collagenase D, Liberase TL, 
and in dispase II (Figure 3). Hyaluronidase did not affect CD56 staining (not shown). The 
CD4 signal was rapidly lost upon incubation with dispase II and Liberase TL (Figure 4). 
There was a mild decrease in CD4 staining after incubation in collagenase D (Figure 4), 
and hyaluronidase had no effect (not shown). In summary, incubation of PBMCs in 
digestive enzymes reduced the MFI of key surface markers. We next examined whether 
modifications of the digestion and staining protocol would mitigate these unwanted 
surface marker changes. 
 
Figure 3. PBMCs were incubated in digestive enzyme for 0, 20, 40, 60 minutes at 37° C. Cells 
were then analyzed by flow cytometry. Displayed are viable lymphocytes (middle right panel in 
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Figure 2). With increased exposure time to each of the enzymes, the MFI of CD56 gradually 
decreased while the CD3 signals remained unchanged. 
 
 
Figure 4. PBMCs were incubated in digestive enzyme for 0, 20, 40, 60 minutes at 37° C. Cells 
were then analyzed by flow cytometry. Displayed are CD3+αβTCR+ cells (bottom left panel in 
Figure 2). MFI of CD4 with small decrease over time in collagenase D, a moderate decrease in 
Liberase TL, and a rapid and complete loss of signal in dispase II. 
 
We tested the use of different antibody clones for CD56 and CD4 reasoning that 
enzymatic digestion might destroy the epitopes of some anti-CD56 and anti-CD4 
antibodies but not others. We tested 4 different clones for CD56 (5.1H11, HCD56, 
MEM188, QA17A16) and 3 different clones for CD4 (RPAT4, SK3, OKT4) in order to 
identify clones specific for more stable epitopes. Overall, while none of the clones we 
tested for CD56 were able to maintain fluorescent signal following enzyme digestion 
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compared to control, Liberase TL had less of an effect than collagenase D (Figure 5). For 
CD4, the OKT4 clone was not affected by Liberase TL or collagenase D digestion 
(Figure 6). 
 
Figure 5. PBMCs were incubated in digestive enzyme for 60 minutes at 37° C. Cells were stained 
with different antibody clones for CD56 and then analyzed by flow cytometry. Displayed are 
viable lymphocytes (middle right panel in Figure 2). The MFI for all clones decreased following 
digestion compared to control. 
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Figure 6. PBMCs were incubated in digestive enzyme for 60 minutes at 37° C. Cells were 
stained with different antibody clones for CD4 and then analyzed by flow cytometry. Displayed 
are CD3+αβTCR+ cells (bottom left panel in Figure 2). There was a decrease in CD4 MFI in 
digested PBMCs after staining with either the RPAT4 or SK3 clone. There was no change in CD4 
MFI for PBMCs stained with the OKT4 clone. 
 
KIR3DL2 fluorescence was not affected by collagenase D while Liberase TL 
completely eliminated staining for KIR3DL2. We attempted to rescue the KIR3DL2 
signal by allowing cells to rest prior to flow cytometry analysis. Figure 7 shows that there 
was incomplete recovery of KIR3DL2 signal after resting the cells for 4 or 12 hours, 
respectively.  
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Figure 7. PBMCs were incubated in digestive enzyme for 40 minutes at 37° C. Cells were 
analyzed by flow cytometry either immediately, after a 4-hour rest in RPMI-C at 37° C, or after a 
12-hour rest. Displayed are NK cells (bottom right panel in Figure 2). The KIR3DL2 signal was 
eliminated after digestion with Liberase TL. There was minimal recovery of signal after resting 
the cells for 4 or 12 hours. No change in KIR3DL2 signal following collagenase D digestion. 
 
Based on these results, the following adjustments were made to the digestion and 
staining protocol: (I) Collagenase D was selected as the digestive enzyme. While it 
caused a slightly greater loss of CD56 signal compared with Liberase TL, collagenase D 
did not alter KIR3DL2 staining (Table 2). (II) An incubation time of 40 minutes was 
selected to balance digestive activity to release lymphocytes with maintaining the CD56 
signal. (III) The OKT4 clone was selected for detecting CD4 as OKT4 staining was not 
impacted by collagenase digestion (Figure 8). 
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Table 2. Summary of how each digestive enzyme altered the MFI for select surface markers. 
RPAT4 used to stain CD4. 
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Figure 8. Change in MFI of CD56 (left) and CD4 (right) after staining with each clone. PBMCs 
were digested in either collagenase D (red) or Liberase TL (green) for 1 hour at 37° C. PBMCs 
stained without being digested (blue) represented 100% MFI. CD4 MFI of PBMCs stained with 
OKT4 had no decrease with digestion. 
 
Detection of Spinal Enthesis Resident Lymphocytes 
When applied to spine tissue, the digestive enzyme protocol released lymphocytes 
from connective tissue and enabled analysis by flow cytometry. The described staining 
panel and gating strategy enabled the detection of lymphocyte populations in the 
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interspinous ligament (Figure 9) and spinous process (Figure 10) similar to those found in 
PBMCs (Figure 2). 
 
Figure 9. Lymphocytes from the interspinous ligament were isolated using digestive method as 
described. Single cell suspensions were then analyzed by flow cytometry, lymphocyte 
populations were gated using the same strategy described in Figure 2. 
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Figure 10. Lymphocytes from the spinous process were isolated using digestive method as 
described. Single cell suspensions were then analyzed by flow cytometry, lymphocyte 
populations were gated using the same strategy described in Figure 2. 
 
The staining panel and gating strategy enabled identification of NK cells, CD4+ T 
cells, CD8+ T cells, double negative αβ T cells, MAIT cells, vδ1 T cells, vδ2 T cells, and 
other γδ T cells in both the interspinous ligament and spinous process bone. 
 
Stimulation of Spinal Enthesis Resident Lymphocytes 
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Next, lymphocytes isolated from interspinous ligament and spinous process were 
activated in vitro by stimulation with PMA/ionomycin for 4 hours. All detectable 
lymphocyte populations stained positive for the cytokines IFNγ and GM-CSF (Figure 
11). CD4+ T cells additionally were positive for IL-17A and IL-22 (Figure 12). MAIT 
cells were also positive for IL-17A (not shown). 
 
Figure 11. Lymphocytes from peripheral blood or isolated from spine tissue were stimulated with 
PMA/ionomycin for 4 hours at 37° C. Lymphocyte populations were gated using the same 
strategy described in Figure 2. GM-CSF and IFNg production are shown for NK cells, CD4+ T 
cells, and CD8+ T cells. 
 
 23 
 
Figure 12. Lymphocytes from peripheral blood or isolated from spine tissue were stimulated with 
PMA/ionomycin for 4 hours at 37° C. Left: Lymphocyte populations were gated using the same 
strategy described in Figure 2. CD4+ T cells were positive for IL-17A and IL-22. Right: Percent 
of CD4+ cells positive for each cytokine from either PBMCs, interspinous ligament, or spinous 
process bone. 
 
When compared to an unmatched sample of PBMCs, lymphocytes isolated from 
spine tissue appeared to exhibit differences in cytokine. The CD4+ T cells from the spine 
had lower fractions of IFNγ producing cells and higher fractions of GM-CSF, IL-17A, 
and IL-22 producing cells compared to unmatched PBMCs (Figure 12). 
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DISCUSSION 
We were able to isolate tissue resident lymphocytes from the interspinous 
ligament and spinous process bone from patients with degenerative disease and analyze 
the cells by flow cytometry using a 17-color panel previously developed for the analysis 
of peripheral blood lymphocytes. We were able to detect the same lymphocyte 
populations identified in peripheral blood, namely NK cells, CD4+ helper T cells, CD8+ 
cytotoxic T cells, double negative αβ T cells, MAIT cells and γδ T cells. Moreover, 
secretion of the AS relevant cytokines IL-17A, IL-22, IFNγ and GM-CSF could be 
demonstrated upon short-term stimulation with PMA/ionomycin in vitro. 
We observed significant changes in extracellular protein levels when analyzed by 
flow cytometry after exposure to digestive enzymes. Of the surface markers included in 
our staining panel, KIR3DL2, CD4, and CD56 were susceptible to signal loss after 
incubation with digestive enzymes. This was likely the result of enzymatic cleavage of 
peptide bonds leading to conformational changes that prevented the fluorochrome-labeled 
antibodies from binding to their epitopes. 
We found some solutions to mitigate the changes that occurred. Alternative clones 
were available for CD56 and CD4. We found that one anti-CD4 clone (OKT4) identified 
its target regardless of exposure to digestive enzymes. Determining the optimal digestive 
enzyme also helped. We compared two collagenase preparations, Liberase TL and 
collagenase D, and found that they had different effects on surface protein levels. The 
CD56 signal decreased less in Liberase TL than in collagenase D. In contrast, KIR3DL2 
staining was eliminated by Liberase TL while it was not changed by collagenase D. As 
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Liberase TL was less detrimental to CD56, we attempted to recover the KIR3DL2 signal 
by allowing cells to rest following incubation in Liberase TL. However, even after 12 
hours of incubation, there was only partial return of the KIR3DL2 signal. While allowing 
the cells to rest longer may further improve signal recovery, we are concerned that 
prolonged incubation might confound the data by decreasing cell viability and artificially 
selecting some cell populations over others. Selecting appropriate digestive enzymes and 
flow cytometry antibody clones is critical when attempting to characterize cells isolated 
from tissue. 
We also examined the feasibility of cryopreserving tissue prior to generating 
single cell suspensions. Cryopreservation has been demonstrated to be effective in 
preserving PBMCs and certain cell types in synovial tissue.3 We compared lymphocyte 
subsets analyzed from fresh spinous process bone to matched tissue that was stored at -
80° C for 14 days in a commercial freezing medium, CryoStor CS10. Cells prepared and 
analyzed after cryopreservation showed no differences in flow cytometry staining 
patterns or frequency of several lymphocyte subsets compared to cells prepared and 
analyzed on the day of surgery (see appendix). 
Cryopreservation has the potential to be highly useful in this research. Our means 
of obtaining spinal tissue rely on patients undergoing spine surgery. These surgeries may 
occur at hours that make immediate tissue processing and analysis impractical. Having 
the ability to quickly preserve tissue for later processing relieves this problem. Moreover, 
tissue samples can be obtained from multiple clinical sites thereby increasing the 
potential pool of donors and permitting centralized tissue processing and analysis. Tissue 
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can also be stored until a sufficient sample size is obtained and processed in parallel to 
reduce batch effects. 
As additional work is done and more data are collected, it is necessary for studies 
to clearly specify the experimental design. We observed differences in cytokine 
production from the same cells after stimulation with PMA/ionomycin in different types 
of media (see appendix). More cells stained cytokine-positive when stimulated in IMDM 
compared to the commonly used RPMI. Another potential source of variability between 
studies is the precise location of the tissue dissected for enzymatic digestion. In this 
study, we used tissue from laminectomy surgeries. While preparing the interspinous 
ligament for cell isolation was straightforward, selecting a defined bone sample proved to 
be quite complicated. Bone pieces were surrounded by soft tissue, which could not be 
completely removed prior to tissue digestion. In addition, bone marrow cells were likely 
included that may not be representative true entheseal cells. A previous study that 
examined spine tissue referred to peri-entheseal bone as a region distinct from entheseal 
soft tissue.2 However, the group did not specify how they determined the peri-entheseal 
region and if it included bone marrow or adjacent soft tissue. While inclusion of multiple 
cell sources does not invalidate the data, specifying the tissue origin of resident 
lymphocytes is important for drawing conclusions and making consistent comparisons. 
This study had a number of weaknesses. Few cells were obtained from the spine 
tissue after digestion. Only 392 CD3+ cells from the interspinous ligament sample were 
evaluated on the flow cytometer. 2,900 CD3+ cells were isolated from the spinous 
process, which likely included cells from the bone marrow as well as the enthesis. For 
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comparison, the PBMC data set included nearly 64,000 CD3+ cells. Several of the 
lymphocyte subsets included in our staining panel represent less than 5% of the total cell 
population. A higher number of analyzed events will improve the accuracy of quantifying 
cell populations with such low frequency. 
Another limitation is the lack of matched samples from the spine and peripheral 
blood of the same patients. However, the primary objective of this study was to optimize 
methods and demonstrate feasibility of analyzing lymphocytes from spine tissue. 
Obtaining matched specimens from spine and peripheral blood will be important for 
future studies. Identifying what types of lymphocytes are present at the spinal enthesis is 
a necessary first step for understanding the pathogenesis of AS. While our findings 
clearly demonstrate immune reactivity in spine tissue, these results are only preliminary 
and qualitative. Increasing the sample size of analyzed tissues will be an important next 
step. Individuals have inherently large variations in lymphocyte fractions. Factors such as 
genetics and medical history may contribute to differences between individuals. As more 
tissue samples are examined, additional variables can be measured. These methods could 
specifically be used to identify HLA-B27 binding KIRs on tissue resident lymphocytes. 
While we did not collect genetic information in this study, future work could easily be 
expanded to include data such as HLA-B27 and compare cells isolated from the spine of 
HLA-B27+ and HLA-B27- individuals. Ultimately, one would like to compare cells from 
patients with AS with non-AS patients. These types of studies will improve our 
understanding AS pathogenesis and open new opportunities for treatment. 
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APPENDIX 
Photomultiplier Tube (PMT) Voltage Optimization 
In the flow cytometer, photons emitted from excited fluorochromes are filtered to 
specific PMTs based on their wavelength. Photons hitting the PMT are amplified across a 
series of dynodes to generate an electrical current that is proportional to the number of 
photons. The flow cytometry software reads the current as a measurement of the cell’s 
fluorescent intensity. Users can modify the voltage of the PMT to optimize the level of 
signal amplification. If the voltage is too low, the user will be unable to distinguish 
positive from negative signals. If the voltage is too high, electrical noise is introduced 
(Figure A2). Optimal voltage settings maximize the separation between positive and 
negative signals while minimizing noise.10 We determined the PMT settings on our flow 
cytometer by calculating the stain index over a range of voltages for each color used in 
our staining panel. 
UltraComp eBeads (Thermo Fisher Scientific) were diluted 1:20 in staining 
buffer. Beads were incubated separately with each antibody from the flow cytometry 
panel in Table 1 at a 1:500 dilution for 30 minutes at 4° C. Following incubation, beads 
were analyzed on a LSRFortessa using 8 different PMT voltage settings in 50 mV 
increments. MFI of positive and negative populations as well as robust standard deviation 
(rSD) of the negative population were calculated using FlowJo. and the stain index was 
calculated at each voltage using the equation in Figure A1. Voltages selected for use are 
listed in Table A1. 
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𝑆𝑡𝑎𝑖𝑛 𝐼𝑛𝑑𝑒𝑥 =
𝑀𝐹𝐼 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 − 𝑀𝐹𝐼 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒
2 × 𝑟𝑆𝐷 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒
 
Figure A1. Stain index calculation.10 
 
 
 
Figure A2. Left: Histogram plots showing signal intensity and separation between unstained 
beads and beads stained with a BV421-labeled antibody. Data were collected for the same sample 
using PMT voltages between 200 mV and 450 mV. Right: Stain index of BV421 over 50 mV 
increments. 
 
 
Color Voltage (mV) Color Voltage (mV) 
BUV395 450 PerCP-Cy5.5 550 
BUV496 450 PE 500 
BV421 350 PE-Dazzle 350 
BV510 400 PE-Cy5 475 
BV605 450 PE-Cy7 500 
BV650 450 APC 550 
BV711 475 Alexa Fluor 700 450 
BV786 475 APC-Cy7 550 
FITC 450   
Table A1. Optimized PMT voltages. 
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Antibody Dilution Titration 
IL-17A and IL-22. 5 wells with approximately 1.5 x 106 PBMCs each were 
stimulated with PMA/ionomycin and stained extracellularly and intracellularly as 
described in methods. The IL-17A and IL-22 antibody were used at dilutions 1:800, 
1:400, 1:200, or 1:100 (Figure A3). 
 
Figure A3. PBMCs were stimulated with PMA/ionomycin as described. Cells were then stained 
for IL-17A and IL-22 at dilutions of either 1:800, 1:400, 1:200, or 1:100 and analyzed by flow 
cytometry. Displayed are CD4+ T cells. 
 
An antibody dilution of 1:100 was selected for both IL-17A and IL-22. At this 
dilution, there was maximum detection of positive staining cells. 
KIR3DL1/DS1. The KIR gene region is variable between individuals allowing for 
numerous possible haplotypes. At the same locus, individuals can contain the allele for 
KIR3DL1, KIR3DS1, neither, or both.20 Because of the differing functions between 
KIR3DL1 and KIR3DS1, it is necessary to be able to differentiate them. However, a flow 
cytometry antibody specific for KIR3DS1 is not available. The Z27 antibody recognizes 
both KIR3DL1 and KIR3DS1.20 When used in conjunction with DX9, an antibody 
specific for KIR3DL1, it is possible to identify KIR3DS1 cells as Z27 positive but DX9 
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negative.20 We tested various dilutions of Z27 and DX9 on PBMCs from a donor known 
to be heterozygous for KIR3DL1 and KIR3DS1. We titrated the dilutions to optimize the 
recognition of cells expressing KIR3DL1 or KIR3DS1 (Figure A4). 
 
 
 
Figure A4. PBMCs were stained with varying concentrations of the DX9 and Z27 antibody 
clones. Cells were analyzed by flow cytometry and gated using the strategy described in Figure 2. 
Top: NK cells stained with increasing concentration of Z27, DX9 held at 1:200. Bottom: NK 
cells stained with increasing concentrations of DX9, Z27 held at 1:100 
 
Based on these results, we decided to use Z27 at 1:100 and DX9 at 1:400 as it provided 
the clearest distinctions between the KIR3DL1 and KIR3DS1 populations. 
 
Incubation Medium Selection 
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One of the primary methods for studying T cell function is to stimulate the cells 
with PMA and ionomycin.22 PMA activates protein kinase C while ionomycin is an 
ionophore that increases cytoplasmic Ca2+ concentration.22 PMA/ionomycin stimulation 
is thought to mimic T cell receptor activation. RPMI has traditionally been used as the 
primary medium for T cell incubation in vitro. However, two recent studies demonstrated 
that T cell activation in IMDM enhances cytokine production, in particular of IL-17A.21,22 
This has been attributed to higher concentration of calcium or aromatic amino acids in 
IMDM compared to RPMI.21,22 
Calcineurin is a calcium dependent protein phosphatase that promotes T cell 
activation.22 Calcineurin dephosphorylates nuclear factor of activated T cell (NFAT) 
which enables NFAT to translocate to the nucleus.22 Once in the nucleus, NFAT induces 
the transcription of imprinted genes leading to the production of numerous cytokines, 
such as IL-17A.22 Another driver of IL-17A production is the aryl hydrocarbon receptor 
(AhR).21 AhR binds to numerous ligands including the amino acids phenylalanine, 
tryptophan, tyrosine, and histidine.21 When stimulated, AhR serves as a transcription 
factor that promotes CD4+ T cells to differentiate into Th17 cells and produce IL-17A.21 
Using PBMCs from 4 different donors, we compared the fraction of cytokine 
producing cells incubated in IMDM compared to cells incubated RPMI. Following 
stimulation, cells were stained for flow cytometry analysis including intracellularly for 
IL-17A, IL-22, IFNγ, and GM-CSF. Fractions of cytokine producing lymphocytes were 
measured with FlowJo (Figure A5). 
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Figure A5. PBMCs from 4 different donors were incubated with PMA/ionomycin in either 
RPMI-C (top row) or IMDM-C (bottom row) for 4 hours and then analyzed by flow cytometry. 
Displayed are CD4+ T cells stained for IL-17A and IL-22. PBMCs incubated in IMDM-C had a 
higher fraction of cytokine induction. 
 
We found that a significantly higher fraction of cells incubated in IMDM during 
stimulation were positive for IL-17A (p = 0.0069) and IL-22, (p = 0.0425) (Figure A6). 
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Figure A6. Fraction of IL-17A (left) and IL-22 (right) positive CD4+ T cells from 4 different 
donors incubated in either RPMI-C or IMDM-C during stimulation with PMA/ionomycin. 
 
Cryopreservation 
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One limiting factor in studying SpA pathology is collecting tissue from a 
sufficient number of donors. Our current method of acquiring specimens relies on 
coordinating with spinal surgeons at multiple clinical sites. Because the prerequisite 
surgery occurs sporadically, we needed a method of preserving cells while collection 
occurred so as samples could be analyzed consistently at a central location. We adapted a 
protocol, previously shown to maintain viability of synovial tissue, to use with ligament 
and bone tissue.3 To ensure that cryopreservation did not alter lymphocyte subpopulation 
proportions or cell phenotype, we compared the profile of lymphocytes isolated from 
spine tissue processed immediately to tissue that underwent cryopreservation. 
Following laminectomy surgery, spinous process bone was cut as described 
above. Three samples of bone from a single donor were analyzed immediately while 
another three samples from the same donor were frozen with the method described above 
and stored at -80° C for 14 days. Lymphocytes from the fresh and cryopreserved tissue 
were isolated and stained for flow cytometry (Figure A7). No significant change, using a 
two-tailed student’s t test, in lymphocyte subset proportions occurred as a result of the 
cryopreservation (Figure A8). 
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Figure A7. Spinous process bone was either analyzed immediately or stored at -80° C for 14 
days. Lymphocytes were isolated using digestion protocol described in methods and analyzed by 
flow cytometry. Lymphocyte populations were gated on using described strategy. No changes in 
fluorescent staining occurred as a result of the cryopreservation. 
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Figure A8. Comparison of spinous process bone from a single donor that was either analyzed 
immediately or stored at -80° C for 14 days. Three samples of bone of both fresh and 
cryopreserved tissue were processed. Lymphocytes were isolated using digestion protocol 
described in methods and analyzed by flow cytometry. Lymphocyte populations were gated on 
using described strategy. There was no change in lymphocyte population fractions as result of 
cryopreservation. 
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Stimulation of Lymphocytes Incubated in Digestive Enzymes 
Enzymatic digestion of connective tissue is necessary to isolate lymphocytes from 
spinal tissue. As shown above, incubating cells in digestive enzymes causes clear 
alterations in their surface proteins. In order to determine if the process of digestion also 
has an effect on lymphocyte’s capability to produce cytokines, we compared fractions of 
cytokine positive PBMCs, stimulated with PMA/ionomycin, that were incubated in the 
digestive enzymes to a matched control. None of the lymphocyte subsets we looked at 
demonstrated a change in cytokine production (Figure A9 and A10). 
 
Figure A9. PBMCs were incubated with or without collagenase D for 40 minutes at 37° C. Cells 
were then stimulated with PMA/ionomycin for 4 hours at 37° C and then analyzed by flow 
cytometry. Displayed are αβ T cell subsets stained for IFNγ and GM-CSF. No change in cytokine 
induction occurred as a result of the digestion. 
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Figure A10. PBMCs were incubated with or without collagenase D for 40 minutes at 37° C. 
Cells were then stimulated with PMA/ionomycin for 4 hours at 37° C and then analyzed by flow 
cytometry. Displayed are γδ T cells and NK cells stained for IFNγ and GM-CSF. No change in 
cytokine induction occurred as a result of the digestion.  
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